Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model

Authors:
Sara Redenšek Trampuž, Sander van Riet, Åsa Nordling & Magnus Ingelman-Sundberg 
In:
Source: Scientific Reports
Publication Date: (2024)
Issue: 14: 1396
Cells used in publication:
Hepatocyte, human
Species: human
Tissue Origin: liver
Endothelial, liver, human
Species: human
Tissue Origin: liver
Experiment

Spheroid cultures

Cryopreserved primary human hepatocytes (PHH) and crude non-parenchymal cells (NPC) were obtained from KaLy-Cell (KLC; Plobsheim, France) and Lonza (Basel, Switzerland). NPC were passaged as previously described22. Donor characteristics of PHH and NPC are listed in Table 1. PHH were seeded in 96-well Corning® Costar® Ultra-Low Attachment Plates (Merck, Kenilworth, NY) or 96-well Nunclon™ Sphera™ U-Shaped-Bottom Microplate (Thermo Fisher Scientific, Waltham, MA) with NPC at a cell ratio of 4:1 (1500:375) as previously described18,22. Spheroids were cultured in William's E medium (Thermo Fisher Scientific) supplemented with 2 mM L-glutamine (Sigma-Aldrich, Saint Louis, MO), 100 units/mL penicillin (Sigma-Aldrich), 100 µg/mL streptomycin (Sigma-Aldrich), 100 nM dexamethasone (Sigma-Aldrich), ITS X-100 (Thermo Fisher Scientific) and 10% fetal bovine serum (FBS; Thermo Fisher Scientific). The medium was changed 5 days after seeding and every 2–3 days thereafter using the medium described above without adding FBS. Induction of liver fibrosis and treatment of spheroids with various substances was initiated 7 days after seeding. The spheroids were harvested on day 14. Spheroids were cultured in 100 µl medium under standard cell culture conditions at 37 °C in a humidified incubator at 5% CO2. Unless otherwise stated, the combination of PHH from donor 1 and NPC from donor 6 was used.

Abstract

Non-alcoholic steatohepatitis (NASH) is a major health problem leading to liver fibrosis and hepatocellular carcinoma, among other diseases, and for which there is still no approved drug treatment. Previous studies in animal models and in LX-2 cells have indicated a role for serotonin (5-HT) and 5-HT receptors in stellate cell activation and the development of NASH. In the current study, we investigated the extent to which these findings are applicable to a human NASH in vitro model consisting of human liver spheroids containing hepatocytes and non-parenchymal cells. Treatment of the spheroids with 5-HT or free fatty acids (FFA) induced fibrosis, whereas treatment of the spheroids with the 5-HT receptor antagonists ketanserin, pimavanserin, sarpogrelate, and SB269970 inhibited FFA-induced fibrosis via a reduction in stellate cell activation as determined by the expression of vimentin, TGF-ß1 and COL1A1 production. siRNA-based silencing of 5-HT2A receptor expression reduced the anti-fibrotic properties of ketanserin, suggesting a role for 5-HT receptors in general and 5-HT2A receptors in particular in the FFA-mediated increase in fibrosis in the human liver spheroid model. The results suggest a contribution of the 5-HT receptors in the development of FFA-induced human liver fibrosis with implications for further efforts in drug development.